References
De Saint-Hubert M, Bauwens M, Verbruggen A, Mottaghy FM. Apoptosis imaging to monitor cancer therapy: the road to fast treatment evaluation? Curr Pharm Biotechnol. 2012;13:571–83.
Bauwens M, De Saint-Hubert M, Cleynhens J, Vandeputte C, Li J, Devos E. In vitro and in vivo comparison of 18 F and 123I-labeled ML10 with 68Ga-Cys2-AnxA5 for molecular imaging of apoptosis. Q J Nucl Med Mol Imaging. 2013;57:187–200.
Allen AM, Ben-Ami M, Reshef A, Steinmetz A, Kundel Y, Inbar E, et al. Assessment of response of brain metastases to radiotherapy by PET imaging of apoptosis with 18 F-ML-10. Eur J Nucl Med Mol Imaging. 2012;39:1400–8.
Hoglund J, Shirvan A, Antoni G, Gustavsson SA, Langstrom B, Ringheim A, et al. 18 F-ML-10, PET tracer for apoptosis: first human study. J Nucl Med. 2011;52:720–5.
ten Berge RL, Meijer CJ, Dukers DF, Alain Kummer J, Bladergroen BA, Vos W, et al. Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma. Blood Journal. 2002;99:4540–54.
Paola EA, Chiara M, Lazzeri E, Minichilli F, Pauwels EK, Sbrana A, et al. Time course of paclitaxel-induced apoptosis in an experimental model of virus-induced breast cancer. J Nucl Med. 2010;51:775–81.
Takei T, Kuge Y, Zhao S, Sato M, Strauss W, Blankenberg FG, et al. Time course of apoptotic tumor response after a single dose of chemotherapy: comparison with 99mTc-annexin V uptake and histologic findings in an experimental model. J Nucl Med. 2004;45:2083–7.
Bodey R, Evans P, Flux G. Spatial aspects of combined modality radiotherapy. Radiother Oncol. 2005;77:301–9.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dizdarevic, S., McCready, R., Turner, J.F.C. et al. Radiolabelled apoptotic probe may be a vehicle for a novel multimodality radionuclide tumour therapy. Eur J Nucl Med Mol Imaging 41, 1255–1256 (2014). https://doi.org/10.1007/s00259-014-2725-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-014-2725-7